Google to resume accepting ads from US addiction treatment centers in July, nearly a year after suspending the category following reports of deceptive ads
Paresh Dave / Reuters :
Context & Ripple Effects
Google's September 2017 suspension of addiction-treatment ads followed reports of deceptive rehab marketing on searches where clicks were lucrative enough to reportedly draw bids of up to $187 per click. The company extended the crackdown to the UK in January, cutting off shady rehab referrers there after an investigative report.
The July resumption announced here is the exit from that freeze: ads return to US addiction-related keywords under a vetting regime, and by August Google had begun running them from close to 100 vetted providers. It matters because it tests whether a platform can re-open a high-value but abuse-prone ad category without recreating the deception that forced the ban.
First-order effects
- Legitimate US addiction treatment centers regain access to high-intent search traffic they lost for nearly a year, now gated through Google's vetting rather than open bidding.
Second-order effects
- Deceptive referrers and lead brokers lose the auction arbitrage that made the category profitable, pushing bad actors toward unvetted channels or adjacent medical keywords still open to them.
Third-order effects
- The vet-then-reopen playbook points toward Google policing sensitive health categories category-by-category — a pattern confirmed when it later banned ads for unproven or experimental medical techniques like most stem cell and gene therapy.
The trend: Search advertising is moving from blanket bans on abusive categories toward curated, verification-gated marketplaces, with Google applying the model across health-adjacent verticals.